To examine this link further, levels of known downstream targets of IL-6 such as BCL-2, STAT-3 and BCLXL33, as well as MMP-1 and MMP-3, were then measured following treatment of colon cancer cell lines with IL-6. This evidence concerns the gene IL6 and malignant colon neoplasm.